L'intérêt à découvert pour KraneShares MSCI All China Health Care Index ETF donne aux investisseurs une idée du degré auquel les investisseurs parient sur la baisse de l'action de KraneShares MSCI All China Health Care Index ETF. Les données sur l'intérêt à découvert sont mises à jour toutes les deux semaines.

KraneShares MSCI All China Health Care Index ETF (ARCA:KURE), Rapport sur les intérêts à découvert

Healthcare

Other

Technology

Consumer Defensive

Consumer Cyclical

Real Estate

Basic Materials

The fund will invest at least 80% of its total assets in components of the underlying index, depositary receipts, including American depositary receipts, representing such components and securities underlying depositary receipts in the underlying index. The underlying index is a free float adjusted market capitalization weighted index designed to track the equity market performance of Chinese companies engaged in the healthcare sector. The fund is non-diversified.

Shenzhen Mindray Bio-Medical Electronics Co Ltd

Beigene Ltd Ord Hkd 0.0001

Legend Biotech Corp

KraneShares MSCI All China Health Care Index ETF

KURE TECHNOLOGIES INC by Kure Technologies, Inc.

Kure Technologies Inc

Kureha Corp

<ul>
<li>Significantly more patients treated with Sotyktu achieved ACR and PASI response rates and had greater improvements in patient-reported quality of life compared with placebo at Week 16</li>
<li>Sotyktu was well-tolerated in comparison with placebo and apremilast, demonstrating safety consistent with its established clinical profile</li>
</ul>

News

Reported Saturday, Bristol Myers Squibb Presents Late-Breaking Phase 3 Data Showing Sotyktu Superior To Placebo In Psoriatic Arthritis

<ul>
<li>Nearly half of patients with moderate-to-severe plaque psoriasis (PsO) treated with icotrokinra achieved completely clear skin (IGA 0) at Week 24 in Phase 3 ICONIC-LEAD study</li>
<li>Topline results from Phase 3 ICONIC-ADVANCE 1&amp;2studies show icotrokinra achieved co-primary endpoints and showed superiority to deucravacitinib in moderate-to-severe PsO</li>
<li>Results pave the way to initiate the first-ever head-to-head study (ICONIC-ASCEND) seeking to demonstrate the superiority of a pill versus injectable biologic in moderate-to-severe PsO</li>
</ul>

PTGX

Reported Saturday, Protagonist Reports Icotrokinra Achieved IGA 0/1 In 74% Of Patients At Week 24 With Favorable Safety Profile

Four Canadian stores of&nbsp;Tesla Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) have been suspected of exploiting the country&#8217;s EV rebate program. The stores are said to have sold an average of 30&nbsp;cars per hour over three days, claiming&nbsp;over 50% of the&nbsp;remaining rebate funds.
What Happened: Four Tesla stores in Canada managed to sell an average of 30 cars per hour, amounting to 120 cars per hour across all four locations, as <a href="https://www.thestar.com/news/canada/tesla-gamed-the-system-canadian-auto-dealers-stiffed-millions-when-u-s-giant-rushed-to/article_6d1025c6-fa0a-11ef-b780-a73277202cb2.html">reported </a>by the Toronto Star on Friday. 
This sales boom lasted for three consecutive days, even during hours when the stores were supposedly closed. Reportedly, a total of 8,653 cars were sold during the final 72 hours of the EV rebate program, also known as the iZEV Program.
Consequently, the Elon Musk-led company applied&nbsp;for C$43.1 million ($30 million) in&nbsp;rebates, which is over&nbsp;half of the remaining C$71.8&nbsp;million ($50 million) allocated for EV&nbsp;rebates.
The iZEV rebate program provided incentives ranging from C$2,500 ($1740.29) to C$5,000 ($3480.57) for purchasing electric vehicles and plug-in hybrids. Dealerships applied the rebate directly to the purchase price, anticipating reimbursement from the government.
Tesla did not immediately respond to <a href="http://pro.benzinga.com">Benzinga&#8217;s</a> request for comment.
As a result of the incident, the rival brands haven&#8217;t been able to access the EV credits as Tesla claimed more than half of them. The Canadian Automobile Dealers Association (CADA), has received rebate claims for 2,295 electric vehicles from 226 dealers who are yet to receive the reimbursement, resulting in a collective shortfall of C$10 million.
CADA&#8217;s spokesperson, Huw Williams, told the Toronto Star, "Somehow, Tesla gamed the system. What we can't figure out is how this could have happened without setting off alarm bells."
Notably, Transport Canada, the body which oversees the iZEV rebate program, has not clarified whether any wrongdoing took place. It also stated that there is no restriction preventing Tesla from submitting rebate paperwork in bulk after delivering sold cars.
SEE ALSO: <a href="https://www.benzinga.com/news/25/03/44211240/warren-buffett-on-debt-and-donald-trumps-money-moves-trump-never-went-right">Warren Buffett on Debt and Donald Trump&#8217;s Money Moves: Trump &#8216;Never Went Right&#8217;</a>
Why It Matters: Tesla has been struggling in Canada, wherein thousands of Canadians have even signed a petition for revoking Musk&#8217;s Canadian citizenship. According to&nbsp;data from shop4tesla.com, the EV maker&#8217;s sales in Canada have dropped by approximately 70% between December 2024 and January 2025.
This surge in sales comes on the heels of Tesla&#8217;s recent offer of lifetime free supercharging for new Foundation Series Cybertruck purchases in Canada. Tesla <a href="https://www.benzinga.com/tech/25/03/44160193/tesla-offers-lifetime-free-supercharging-on-foundation-series-cybertruck-purchases-in-canada-mexico">announced this offer </a>to make the expensive truck more appealing to customers. The offer, valid for orders placed on or after March 5, lasts for the duration of the customer's ownership of the vehicle and is non-transferable.
<ul>
<li>READ MORE: <a href="https://www.benzinga.com/markets/25/03/44212993/palantir-ceo-alex-karp-meets-hyundai-vice-chair-to-enhance-ai-shipyard-defense-collaboration-amid-trumps-call-for-us-shipbuilding-revival">Palantir CEO Alex Karp Meets Hyundai Vice Chair to Enhance AI Shipyard, Defense Collaboration Amid Trump&#8217;s Call for US Shipbuilding Revival</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Markets

TSLA

Tesla Suspected Of EV Rebate Manipulation In Canada Amid Sudden Sales Surge Before Deadline: 'Tesla Gamed The System', Says Industry Body

<ul>
<li>Results presented in AAD late-breaker demonstrate bempikibart's encouraging improvement on SALT reduction at week 24 and continued effects after dosing cessation in patients with severe and very severe alopecia areata (AA) --</li>
<li>Durable, ongoing responses in multiple patients through week 36 follow-up period and beyond to week 55, despite only 24 weeks of dosing, suggestive of potential for remittive effect; multiple inbound patient requests to re-initiate dosing --</li>
<li>In the Phase 2a clinical trial, bempikibart was observed to be safe and well-tolerated, with PK supporting subcutaneous dosing and receptor occupancy data demonstrating desired target engagement; clinical biomarkers showed changes in Th2 biomarkers, and expected on-mechanism changes in T-cells, indicative of potent IL-7 and TSLP inhibition --</li>
<li>Bempikibart development program remains on track with open-label extension study to initiate in 1H'25; SIGNAL-AA Part B remains on track for initiation of dosing in 1H'25, with topline data expected in 1H'26 --</li>
</ul>

QTTB

Reported Saturday, Q32 Bio Presents Phase 2a Data Showing Bempikibart Induces Sustained Hair Regrowth Post-Treatment In Severe Alopecia Areata

<ul>
<li>Late-breaking results presented at AAD show 80% or more scalp hair coverage at Week 36 in 42.4% of adolescents receiving baricitinib 4 mg</li>
<li>Patients treated with&nbsp;baricitinib 4 mg saw significant regrowth of eyebrows and eyelashes at Week 36 compared to placebo</li>
<li>Positive data underscore Lilly's continued expansion across dermatologic conditions, with treatments that can improve outcomes for patients with the greatest need</li>
</ul>

INCY

Reported Saturday, Lilly And Incyte Present Late-Breaking Phase 3 Data Showing Baricitinib Significantly Improves Scalp, Eyebrow, And Eyelash Regrowth In Teens With AA

Macro Economic Events

Econ #s

Economics

Germany Trade Balance For January 16.0B Vs. 21.0B Est.; 20.7B Prior

Germany Industrial Production (MoM) For January 2.0% Vs. 1.6% Est.; -2.4% Prior

<ul>
<li>Tour 2025 Presented by Snapdragon, will see Manchester United return to the US for the third consecutive year, joining Premier League Summer Series for the first time</li>
<li>The round-robin series features three fixtures, with United set to face West Ham in New Jersey (26 July), AFC Bournemouth in Chicago (30 July) and Everton in Atlanta (3 August)</li>
</ul>

MANU

Reported Sunday, Manchester United To Play In Premier League Summer Series For First Time As Part Of Tour 2025 Presented By Snapdragon

CRT 2025 Late Breaking Science features largest head-to-head randomized control TAVR trial&nbsp;to primarily enroll women using the two most widely used global TAVR devices

Reported Sunday, Medtronic Evolut TAVR Demonstrates Superior Durability And Valve Function In Small Annulus Patients, SMART Trial Shows

A subsidiary of Xpeng Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPEV#NYSE">XPEV</a>) (OTC:<a class="ticker" href="https://www.benzinga.com/stock/XPNGF#OTC">XPNGF</a>), a Chinese electric vehicle maker and Tesla Inc.&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) rival, plans to become the world&#8217;s first mass producer of <a href="https://in.benzinga.com/insights/options/25/03/44111960/xpeng-options-trading-a-deep-dive-into-market-sentiment">flying cars by 2026</a>.
What Happened: Xpeng Aeroht&#8217;s &#8220;land aircraft carrier&#8221; — a modular vehicle featuring a passenger drone that unfolds from a six-wheeled van — completed its first public flight at the November Zhuhai Airshow and has reportedly secured approximately 3,000 intended orders, <a href="https://www.straitstimes.com/asia/mass-production-of-flying-cars-in-sight-amid-chinas-low-altitude-economy-push">reported</a> The Straits Times.
&#8220;In 2026, Xpeng plans to mass produce, for the first time, our modular flying car,&#8221; Xpeng Chairman and CEO He Xiaopeng said on Friday. The company broke ground in October on a factory designed to produce 10,000 flying cars annually when completed in the first quarter of 2026.
Priced at no more than 2 million yuan ($275,000), the vehicle accommodates four passengers in the car portion and two in the detachable drone. Initial applications will likely focus on tourism and short-haul rescue missions rather than everyday transportation.
See Also:&nbsp;<a href="https://www.benzinga.com/markets/equities/25/03/44212386/stock-futures-drop-as-reverse-trump-trade-takes-holdpeter-schiff-says-market-shift-long-overdue-and-will-likely-continue-for-a-decade" target="_blank" rel="noreferrer noopener">Stock Futures Drop As ‘Reverse Trump Trade' Takes Hold—Peter Schiff Says Market Shift ‘Long Overdue' And Will Likely Continue For A Decade</a>
Why It Matters: China&#8217;s government has prioritized the &#8220;low-altitude economy&#8221; — economic activity below 1,000 meters — labeling it a &#8220;new growth engine&#8221; in its 2024 annual work report. The sector, projected to reach one trillion yuan ($138 billion) by 2025, encompasses drone deliveries, <a href="https://www.benzinga.com/news/24/10/41551820/flying-taxis-are-almost-here-joby-archer-aviation-applaud-new-faa-regulations-for-evtol-aircraft">air shuttles, and flying taxis</a>.
Regulatory hurdles remain the primary challenge. He Xiaopeng cited concerns about vehicle certification, takeoff regulations, and pilot licensing requirements. &#8220;Right now, I see many problems,&#8221; he acknowledged.
Xpeng&#8217;s ADR stock on NYSE rose 6.16% to $23.60 in Friday&#8217;s trading, though analysts maintain an <a href="https://www.benzinga.com/quote/XPEV/analyst-ratings">average price target</a> of $17.44, suggesting a potential 37.04% downside ahead of the company&#8217;s fourth-quarter earnings report due Mar. 18.
<figure class="wp-block-image aligncenter size-full is-resized"><img decoding="async" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/10020824/Screenshot-2025-03-10-at-11.35.56%E2%80%AFAM.png" alt="" class="wp-image-815913" style="width:694px;height:auto" /></figure>
Price Action: Xpeng traded at 88.85 HKD ($11.43) on the Hong Kong Exchange as of Monday at 1:21 PM local time, down 1.28% for the day.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/25/03/44212672/jamie-dimon-cashed-out-234-million-in-jpmorgan-stock-warren-buffett-stockpiled-334-billion-in-cash-weeks-later-markets-crashed-coincidence" target="_blank" rel="noreferrer noopener">Jamie Dimon Cashed Out $234 Million In JPMorgan Stock, Warren Buffett Stockpiled $334 Billion In Cash — Weeks Later, Markets Crashed. Coincidence?</a></li>
</ul>
Image Via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Asia

Equities

XPEV

XPNGF

Tesla Rival XPeng Aims To Mass-Produce Flying Cars By 2026, But Regulators May Ground Takeoff

<ul>
<li>Authorized share increase approval supports the FX strategy and continued deliveries of the FF 91 2.0.</li>
<li>Company stock ticker to officially change to "FFAI" starting March 10, 2025.</li>
</ul>

FFIE

Reported Earlier, Faraday Future Gains Shareholder Backing To Raise Capital, Issue Shares For Operations, And Accelerate FX Project

MEOH

Reported Earlier, Methanex Geismar 3 Plant Outage To Impact Q2 Sales, Repair Costs Not Expected To Be Material

BTDR

Reported Earlier, Bitdeer Completes SEAL03 Chip Testing, Achieves 9.7J/TH Power Efficiency Ahead Of SEALMINER A3 Launch

<ul>
<li>Will add UNLOXCYT&#x2122; (cosibelimab-ipdl), the first and only FDA-approved anti-PD-L1 treatment for metastatic or locally advanced cutaneous squamous cell carcinoma (cSCC) to Sun Pharma's global onco-derm franchise</li>
<li>Will leverage Sun Pharma's global presence to accelerate patient access to UNLOXCYT&#x2122; (cosibelimab-ipdl)</li>
<li>Upfront cash payment of $4.10 per share of common stock, representing aggregate upfront consideration of up to $355 million Stockholders will also receive a contingent value right for up to $0.70 per share on achievement of a milestone</li>
</ul>
&nbsp;

CKPT

Reported Earlier, Sun Pharma To Acquire Checkpoint Therapeutics In $355M Deal, Adding FDA-Approved UNLOXCYT For Advanced cSCC To Onco-Derm Portfolio

End-to-End Virtual Prototyping Workflows Enable Faster Software Development and Time to Market for Automotive, HPC and IoT System

SNPS

Synopsys Launches Virtualizer Native Execution On Arm To Accelerate SDV And Edge Software Development

Joint Solution to Drive Adoption of "Shift-Left" Software Development Methodologies with the Integration of Synopsys' Electronics Digital Twin Capabilities and Vector's Software Factory

Vector And Synopsys Partner To Advance Shift-Left With Cloud-Ready Software Factory Tools

Key Highlights for February 2025:
<ul>
<li>Bitcoin Production: Mined 89 BTC, bringing HIVE's HODL portfolio to 2,620 BTC, valued at $220 million as of February 28, 2025, based on a BTC closing price of approximately $84,000.</li>
<li>HODL Update: The Company's Bitcoin holdings have increased by 23% year-over-year. However, on a month-over-month basis, BTC holdings saw a decline as HIVE strategically sold a portion of its BTC to invest in capital assets, including Bitfarms' 200 megawatt ("MW") hydro-powered Bitcoin mining assets in Paraguay.</li>
<li>Mining Capacity: Maintained an average mining capacity of 5.6 Exahash per Second ("EH/s") with fleet efficiency at 20.9 Joules per Terahash ("J/TH"). HIVE achieved a peak BTC-only hashrate of 6.2 EH/s and a peak BTC-equivalent hashrate of 6.4 EH/s.</li>
<li>Operational Efficiency: Achieved an average daily production rate of 3.2 BTC, equivalent to 16 BTC per Exahash.</li>
</ul>

HIVE

HIVE Digital Mined 89 BTC In February, Growing HODL Portfolio To 2,620 BTC Valued At $220M

Earlier this month, top executives from South Korea&#8217;s shipbuilding conglomerate Hyundai Heavy Industries Group and Palantir Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>) met to push forward AI-driven shipyard innovation and future defense capabilities.
What Happened: HD Hyundai executive vice Chairman Chung Kisun visited Washington, D.C., to meet with Palantir CEO Alex Karp and discuss the companies&#8217; <a href="https://www.benzinga.com/news/22/09/28943372/palantir-hyundai-consolidate-partnership-expanding-into-shipbuilding">ongoing collaboration on building</a> an AI-powered shipyard.
The two leaders reviewed the progress of their &#8220;Future of Shipyard&#8221; (FOS) initiative, launched in 2021, and explored potential defense-related applications of artificial intelligence.
According to HD Hyundai, the companies agreed that AI-based defense solutions could play a pivotal role in national security strategies for both South Korea and the U.S.&nbsp;
Chung's visit comes as part of his U.S. tour to attend CERA Week, the major global energy conference taking place in Houston from March 10–14.
See Also: <a href="https://in.benzinga.com/government/regulations/25/03/44190445/palantir-delivers-ai-powered-battle-stations-to-us-army-stock-now-comparable-to-tesla-circa-2015-analyst">Palantir Delivers AI-Powered Battle Stations To US Army, Stock Now Comparable To Tesla Circa 2015: Analyst</a>
Why It's Important: The FOS project aims to complete the construction of an intelligent, autonomous shipyard by 2030, targeting a 30% boost in productivity and a 30% reduction in construction time.
In addition, the companies are co-developing an unmanned surface vessel (USV) named &#8220;TENEBRIS,&#8221; and collaborating through HD Hyundai Infracore.
This deepening partnership comes at a time of strong momentum for Palantir. Last month, the company reported <a href="https://in.benzinga.com/news/earnings/25/02/43449486/palantir-q4-earnings-revenue-beat-eps-beat-us-revenue-up-52-customer-count-up-43-strong-guidance-this-is-a-new-phase-unlike-anything-that-has-come-before">fourth-quarter revenue</a> of $827.52 million, beating analyst expectations of $775.91 million.&nbsp;
With this, Palantir has topped analyst projections for six consecutive quarters, with U.S. revenue rising 52% year-over-year. Its U.S. commercial business surged 64%, while government revenue increased 45%.
Meanwhile, on Sunday, VOA <a href="https://www.voanews.com/a/trump-pledges-to-resurrect-shipbuilding-as-china-seen-outpacing-us-/8004070.html">reported</a> that the U.S. Navy's fleet is shrinking despite efforts to expand, with more ships being decommissioned than built. Meanwhile, China's fleet is rapidly growing.
Major shipbuilders like BAE Systems and Huntington Ingalls Industries are operating below capacity due to inconsistent Navy contracts and budget delays. Meanwhile, President Donald Trump has vowed to create a new White House office to boost U.S. military and commercial shipbuilding.
Price Action: Palantir shares closed 5.52% higher at $84.90 on Friday but dipped 0.098% in after-hours trading, according to <a href="http://pro.benzinga.com/">Benzinga Pro</a>.
Image via Shutterstock
Also Read:
<ul>
<li><a href="https://www.benzinga.com/25/03/44149586/credo-expands-hyperscaler-partnerships-with-amazon-microsoft-xai-amid-nvidia-powered-ai-boom" target="_blank" rel="noreferrer noopener">Analysts Highlight Credo Hyperscaler Partnerships With Amazon, Microsoft, xAI Amid AI Boom</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.

Tech

PLTR

Palantir CEO Alex Karp Meets Hyundai Vice Chair to Enhance AI Shipyard, Defense Collaboration Amid Trump's Call for US Shipbuilding Revival

On Sunday, Apple Inc.'s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) services chief Eddy Cue shared insights into Apple TV+'s selective content strategy while praising the global success of &#8220;Severance," calling it one of the most culturally impactful shows of recent years.
What Happened: During a panel at the SXSW festival in Austin, Texas, Cue joined actor-director Ben Stiller for a wide-ranging discussion on the breakout success of Severance and Apple TV+'s content approach.
"It's been a long time since we've seen a show capture the imagination like this," Cue said of Severance, which Apple says is now its <a href="https://in.benzinga.com/general/entertainment/25/02/43855319/apple-stock-set-for-streaming-lift-severance-breaks-record-after-x-ads-tim-cook-promo">most-watched series ever</a> on the platform.
Despite having early access to episodes, Cue admitted he still waits for each weekly drop: "I tend to wait… I just love the storytelling."
See Also:&nbsp;<a href="https://www.benzinga.com/markets/25/03/44133360/apple-challenges-uks-backdoor-order-in-landmark-legal-case-after-trump-compares-directive-to-china-style-surveillance-report" target="_blank" rel="noreferrer noopener">Apple Challenges UK's ‘Backdoor' Order In Landmark Legal Case After Trump Compares Directive To China-Style Surveillance: Report</a>
Cue emphasized Apple TV+'s strategy of focusing on quality over quantity. "We're not going to throw 20 shows up against the wall and hope that one sticks," he said. "The ones that we do — they all need to stick. Otherwise, we have nothing else."
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="Ben Stiller Talks &quot;Severance&quot; with Apple TV&#039;s Eddy Cue &#x7C; SXSW 2025" width="500" height="281" src="https://www.youtube.com/embed/6O1rzh8ytLU?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Subscribe to the&nbsp;<a href="https://bztechtrends.beehiiv.com/subscribe" target="_blank" rel="noreferrer noopener">Benzinga Tech Trends newsletter</a>&nbsp;to get all the latest tech developments delivered to your inbox.
Why It's Important: Cue's remarks highlight Apple's continued focus on prestige programming in a crowded streaming landscape.
Rather than <a href="https://www.benzinga.com/topic/streaming">emulate rivals like</a> Netflix Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) with a high-volume output, as Cue highlighted, Apple TV+ plans to carve out a niche with select, critically acclaimed titles.
Severance, created by Dan Erickson and directed by Stiller, explores a dystopian workplace where employees are surgically separated from their personal lives.
With appearances by Adam Scott, Patricia Arquette, and Christopher Walken, Severance is shaping up to be Apple TV+'s flagship franchise.
Now in its second season, the series has earned critical acclaim and a cult following. Apple has already confirmed a third season is in development.
Unlike Netflix shows that drop all episodes at once for binge-watching, &#8220;Severance&#8221; follows a weekly release schedule, with its season 2 finale set for March 21.
Apple&#8217;s streaming service costs $9.99 per month, making it one of the <a href="https://www.benzinga.com/general/entertainment/24/07/40014040/apple-to-follow-netflix-disney-ad-supported-appletv-streaming-plan-could-launch-soon">more affordable ad-free options</a> available.
Price Action: Apple&#8217;s stock ended Friday at $239.07, gaining 1.59%. It later slipped 0.15% in after-hours trading, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro data</a>.
Photo by Ivan Marc on Shutterstock
Check out more of Benzinga&#8217;s Consumer Tech coverage by&nbsp;<a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/media/25/03/44207932/apple-delays-next-gen-siri-its-going-to-take-us-longer-than-we-thought-to-deliver-ai-upgrades">Apple Delays Next-Gen Siri: &#8216;It&#8217;s Going To Take Us Longer Than We Thought&#8217; To Deliver AI Upgrades</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.

Entertainment

AAPL

NFLX

Eddy Cue Praises 'Severance' For Breaking Through The Noise Globally, Says Apple TV+ Isn't Going To Throw 20 Shows On The Wall Hoping One Will Stick

The CNN Money Fear and Greed index showed some improvement in the overall market sentiment, while the index remained in the &#8220;Extreme Fear&#8221; zone on Friday.
U.S. stocks settled higher on Friday, with the Dow Jones index gaining more than 200 points during the session. However, the index recorded losses last week.
The S&amp;P 500 recorded its worst week since September, falling 3.1% last week. The Dow declined 2.4%, while the Nasdaq Composite tumbled 3.5% during the week.
On the economic data front, the February jobs report from the Bureau of Labor Statistics, released Friday, showed a moderate increase in employment and also a slight increase in the unemployment rate.
The U.S. economy added 151,000 jobs in February, up from a downwardly revised 125,000 in January, but below expectations of 160,000, as tracked by Trading Economics. The unemployment rate ticked unexpectedly higher to 4.1%, above the 4.0% expected.
Genesco Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GCO#NYSE">GCO</a>) shares dipped over 16% on Friday after the company reported worse-than-expected fourth-quarter financial results. American Public Education Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APEI#NASDAQ">APEI</a>) shares surged 22% after the company reported better-than-expected quarterly financial results.
Most sectors on the S&amp;P 500 closed on a positive note, with utilities, information technology and energy stocks recording the biggest gains on Friday. However, consumer staples and financial stocks bucked the overall market trend, closing the session lower.
The Dow Jones closed higher by around 223 points to 42,801.72 on Friday. The S&amp;P 500 rose 0.55% to 5,770.20, while the Nasdaq Composite climbed 0.70% at 18,196.22 during Friday's session.
Investors are awaiting earnings results from BioNTech SE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNTX#NASDAQ">BNTX</a>), Oracle Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>) and Vail Resorts Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTN#NYSE">MTN</a>) today.
What is CNN Business Fear &amp; Greed Index?
At a current reading of 20.5, the index remained in the &#8220;Extreme Fear&#8221; zone on Friday, versus a prior reading of 17.8.
The Fear &amp; Greed Index is a measure of the current market sentiment. It is based on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/03/44189784/how-to-earn-500-a-month-from-oracle-stock-ahead-of-q3-earnings">How To Earn $500 A Month From Oracle Stock Ahead Of Q3 Earnings</a></li>
</ul>
Photo courtesy: Shutterstock

Comments

KraneShares MSCI All China Health Care Index ETF

Intérêt court

KraneShares MSCI All China Health Care Index ETF (ARCA:KURE), Rapport sur les intérêts à découvert

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL